Health ❯ Healthcare ❯ Drug Development

FDA Regulations

Fast Track Designation Drug Availability Drug Shortages Animal Testing Alternatives Breakthrough Therapy Designation Efficacy Studies

Apnimed Pill Cuts Sleep Apnea Events in Phase 3 as Company Seeks FDA Approval

The once-nightly therapy targets airway muscle tone to give patients who cannot use CPAP a possible oral alternative.

ATyr’s Sarcoidosis Drug Fails Phase 3 Goal, Shares Plunge Over 80%